ResearchMoz

Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and Anti-Arrhythmic Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-10-10
No. Of Pages » 88
 Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart’s electrical system. Atrial fibrillation (AF) is one of the most commonly occurring cardiac rhythm conditions. Being a potentially life threatening disease and expensive to treat, the overall healthcare system views the treatment for this condition as a strategically critical area to address. This report analyzes the market for atrial fibrillation market from the point of view of various pharmacological and non-pharmacological treatment products used for the treatment of AF.  
   
 The pharmacological AF treatment market has been further classified into the specific drugs commonly used for treating AF, namely anti-arrythmics and anti-coagulants....
Table of Content

Chapter 1 Preface
1.1 Report description
1.2 Market segmentation
1.3 Research methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Rising global base of geriatric population
3.2.1.2 Favorable results exhibited by clinical trials aimed at treating atrial fibrillation
3.2.1.3 Rising prevalence of disorders such as hypertension and obesity accelerating the incidence rate of atrial fibrillation
3.2.2 Restraints
3.2.2.1 Stringent FDA, CE and European Medicines Agency product approval regulations
3.2.3 Opportunities
3.2.3.1 Introduction of innovative treatment procedures
3.2.3.2 Rising prevalence of atrial fibrillation in emerging Asian economies
3.3 Porter’s Five Forces Analysis for the Global Atrial Fibrillation Market
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Competitive Rivalry

Chapter 4 Atrial Fibrillation Market, by Treatment Types
4.1 Overview
4.1.1 Global Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.2 Global Pharmacological Treatments for Atrial Fibrillation Market
4.2.1 Global Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.2.2 Global Anti-Arrhythmic Drugs Market
4.2.2.1 Global Anti-Arrhythmic Drugs Market, 2011 – 2019 (USD Million)
4.2.3 Global Anti-Coagulants Market
4.2.3.1 Global Anti-Coagulant Drugs for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3 Non-Pharmacological Treatment for Atrial Fibrillation Market
4.3.1 Overview: Comparative Analysis of the Non-Pharmacological Treatment for Atrial Fibrillation Market
4.3.2 Global Non-Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3 Global Catheter Ablation Treatment for Atrial Fibrillation Market
4.3.3.1 Overview
4.3.3.2 Global Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.3 Global Radiofrequency Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.4 Global HIFU (High Intensity Focused Ultrasound) Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.5 Global Cryoablation Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.6 Global Microwave Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.7 Global Laser Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.4 Global Maze Surgery for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.5 Global Electric Cardioversion for Atrial Fibrillation Market, 2011 – 2019 (USD Million)

Chapter 5 Atrial Fibrillation Market, by Geography
5.1 Overview
5.2 North America
5.2.1 North America Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
5.3 Europe
5.3.1 Europe Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 RoW Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)

Chapter 6 Competitive Landscape

Chapter 7 Recommendations
7.1 Investing in emerging markets, particularly China and Brazil
7.2 Focus on emerging technologies such as mini-maze procedure and catheter ablation

Chapter 8 Company Profiles
8.1 AtriCure, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.2 Biosense Webster, Inc.
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Business Strategies
8.3 Boehringer Ingelheim GmbH
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.5 Bristol-Myers Squibb Corporation
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.6 CardioFocus, Inc.
8.6.1 Company Overview
8.6.2 Product Portfolio
8.7 Endoscopic Technologies, Inc.
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Business Strategies
8.8 Sanofi Aventis
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.9 St. Jude Medical, Inc.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.10 Johnson and Johnson Ltd
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies

List of Tables


TABLE 1 Market Snapshot: Global Atrial Fibrillation Market
TABLE 2 Impact analysis of the Market Drivers for the Global Atrial Fibrillation Market
TABLE 3 Impact analysis of the Market Restraints for the Global Atrial Fibrillation Market
TABLE 4 Anti-Arrhythmic Drug Types and Clinical Usage
TABLE 5 Anti-Arrhythmic Drugs: Classification and Clinical Usage
TABLE 6 North America Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 
TABLE 7 Europe Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 
TABLE 8 Asia-Pacific Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 
TABLE 9 RoW Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)

List of Figures

FIG. 1 Market Segmentation: Global Atrial Fibrillation Market
FIG. 2 Global Atrial Fibrillation Market, by Treatment Types, 2012 (USD Million)
FIG. 3 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 4 Porter’s Five Forces Analysis for the Global Atrial Fibrillation Market
FIG. 5 Comparative Analysis of the Global Atrial Fibrillation Market, by Treatment Types, 2012 & 2019 (%)
FIG. 6 Global Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 7 Global Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 8 Global Anti-Arrhythmic Drugs Market, 2011 – 2019 (USD Million)
FIG. 9 Global Anti-Coagulant Drugs for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 10 Comparative Analysis of the Non-Pharmacological Treatment for Atrial Fibrillation Market
FIG. 11 Global Non-Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 12 Comparative Analysis: Catheter Ablation Treatment Types for the Atrial Fibrillation Market
FIG. 13 Global Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 14 Global Radiofrequency Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 15 Global HIFU (High Intensity Focused Ultrasound) Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 16 Global Cryoablation Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 17 Global Microwave Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 18 Global Laser Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 19 Global Maze Surgery for Atrial Fibrillation Market, 2013 – 2019 (USD Million)
FIG. 20 Global Electric Cardioversion for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 21 Comparative Analysis of the Global Atrial Fibrillation Market, by Geography, 2012 & 2019 (%)
FIG. 22 North America Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 23 Europe Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 24 Asia-Pacific Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 25 RoW Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 26 AtriCure Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Boehringer Ingelheim: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 Boston Scientific: Annual sales revenue, 2010 – 2012 (USD Million)
FIG. 29 Bristol-Myers Squibb: Annual sales revenue, 2010 – 2012 (USD Million)
FIG. 30 Sanofi: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 St. Jude Medical: Annual Sales Revenue,2010 – 2012 (USD Million)
FIG. 32 Johnson and Johnson: Annual Revenue, 2010 – 2012 (USD Million)

Upcoming Reports:

Rhinoconjunctivitis Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Rhinoconjunctivitis is a combination of rhinitis and conjunctivitis and is one of the most common allergic reactions across the globe. It is an inflammatory disorder which affects nasal and conjunctival mucosa and is induced as a result of hypersensitive immune response. Rhinoconjunctivitis causes symptoms of allergic rhinitis such as sneezing, watery mucus, itchy nose, and nasal congestion, as well as conjunctivitis which include burning sensation, tears and redness of eyes. These symptoms may also be accompanied by systemic symptoms such as poor sleep, irritability and fatigue. Allergic...
Greece: market of printed newspapers, journals and periodicals
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the printed newspapers, journals and periodicals market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the printed newspapers, journals and periodicals market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018....
Tantalum Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Tantalum is a hard, bluish grey, transition metal. Previously it was known as tantalium and is a rare earth metal. It is characterized by its incredibly high melting point which is bettered only by tungsten, rhenium, osmium and carbon. Tantalum along with similar metals such as Neobium, can be found in minerals such as coltan, columbite and tantalite. Most of the tantalum is derived from hard rock mines; however it can also be obtained from tin slags, and artisanal mines. Tantalite is highly resistant to corrosion and is a part of the refractory metals group.  The main...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...